Infective endocarditis (IE) is a consequence of the localized or systemic diffusion of pathogens, generally bacteria or fungi, in the heart. Complications of heart valve endocarditis (HVE) develops in approximately from 1% to 43% of patients. Development of any degree of valve regurgitation in patients with LV dysfunction have a higher mortality risk than those without valve regurgitation. This fact alone remains the primary driver for surgery in patients with HVE.
Sharing of decision-making for infective endocarditis surgery: a narrative review of clinical and ethical implications
Guidelines on prosthetic heart valve management in infective endocarditis: a narrative review comparing American Heart Association/American College of Cardiology and European Society of Cardiology guidelines
A narrative review of early surgery versus conventional treatment for infective endocarditis: do we have an answer?
The quest for the optimal surgical management of tricuspid valve endocarditis in the current era: a narrative review
The series “Infective Endocarditis in the 21st Century” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Francesco Nappi, Christos Mihos and Cristiano Spadaccio served as the unpaid Guest Editors for the series.